| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -17,260 | -12,694 |
| Stock-based compensation | 19,547 | 13,321 |
| Depreciation and amortization | 4,132 | 2,646 |
| Accounts receivable credit losses | 537 | 475 |
| Amortization of discount and premium on marketable securities | 2,440 | 1,740 |
| Inventory reserve | 1,784 | 1,235 |
| Amortization of debt issuance costs | 88 | 59 |
| Loss on disposal of property and equipment | -1,442 | -628 |
| Accounts receivable | -364 | -2,598 |
| Inventory | 10,334 | 8,292 |
| Prepaid expenses and other assets | -419 | 93 |
| Accounts payable | 1,245 | 583 |
| Accrued liabilities and other | -1,927 | -3,464 |
| Net cash used in operating activities | -2,403 | -4,738 |
| Maturities of marketable securities | 156,100 | 104,100 |
| Purchases of marketable securities | 157,840 | 98,770 |
| Purchases of property and equipment | 7,126 | 4,171 |
| Net cash (used in) provided by investing activities | -8,866 | 1,159 |
| Proceeds from issuance of common stock under employee stock purchase plan | 1,568 | 1,568 |
| Proceeds from the exercise of stock options | 779 | 768 |
| Net cash provided by financing activities | 2,347 | 2,336 |
| Effect of exchange rate changes on cash and cash equivalents | 461 | 445 |
| Net decrease in cash and cash equivalents | -8,461 | -798 |
| Cash and cash equivalents at beginning of period | 34,948 | - |
| Cash and cash equivalents at end of period | 26,487 | - |
SI-BONE, Inc. (SIBN)
SI-BONE, Inc. (SIBN)